Literature DB >> 20352224

A case of Degos disease successfully treated with corticosteroid combined with cyclophosphamide.

Tomohiro Kameda1, Hiroaki Dobashi, Kozo Yoneda, Kentaro Susaki, Toshiya Kuno, Koji Murao, Toshihiko Ishida.   

Abstract

Degos disease is a rare disorder characterized by systemic vasculitis involving various organs. There is no established, effective treatment for the disorder, and its prognosis is still poor. Combination therapy with corticosteroid and cyclophosphamide is considered effective for vasculitides involving the small arteries such as ANCA-associated vasculitis. We present here a 42-year-old man who developed Degos disease over several months, and was successfully treated using combined treatment with corticosteroid and cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352224     DOI: 10.1007/s00296-010-1436-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

Review 1.  Degos' disease: a distinctive pattern of disease, chiefly of lupus erythematosus, and not a specific disease per se.

Authors:  Elizabeth Ball; Amy Newburger; A Bernard Ackerman
Journal:  Am J Dermatopathol       Date:  2003-08       Impact factor: 1.533

Review 2.  Systemic vasculitis treatment and monitoring update, 2008.

Authors:  Yusuf Yazici
Journal:  Bull NYU Hosp Jt Dis       Date:  2008

3.  Degos disease: considerations for reclassification.

Authors:  Warren R Heymann
Journal:  J Am Acad Dermatol       Date:  2009-09       Impact factor: 11.527

4.  BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

Authors:  C Lapraik; R Watts; P Bacon; D Carruthers; K Chakravarty; D D'Cruz; L Guillevin; L Harper; D Jayne; R Luqmani; J Mooney; D Scott
Journal:  Rheumatology (Oxford)       Date:  2007-09-05       Impact factor: 7.580

5.  Malignant atrophic papulosis (Degos' disease) involving three generations of a family.

Authors:  S K Katz; L J Mudd; H H Roenigk
Journal:  J Am Acad Dermatol       Date:  1997-09       Impact factor: 11.527

6.  Papulosis atrophicans maligna (Köhlmeier-Degos disease): a disseminated occlusive vasculopathy.

Authors:  H R McFarland; W G Wood; B V Drowns; A C Meneses
Journal:  Ann Neurol       Date:  1978-05       Impact factor: 10.422

7.  Benign cutaneous Degos disease.

Authors:  Mozheh Zamiri; Paul Jarrett; John Snow
Journal:  Int J Dermatol       Date:  2005-08       Impact factor: 2.736

Review 8.  Malignant atrophic papulosis.

Authors:  R Degos
Journal:  Br J Dermatol       Date:  1979-01       Impact factor: 9.302

Review 9.  Malignant atrophic papulosis of Degos. Report of a patient who failed to respond to fibrinolytic therapy.

Authors:  S M Howsden; S J Hodge; J H Herndon; R G Freeman
Journal:  Arch Dermatol       Date:  1976-11

Review 10.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

View more
  1 in total

1.  Successful treatment of neurological malignant atrophic papulosis in child by corticosteroid combined with intravenous immunoglobulin.

Authors:  Yi-Feng Guo; Wei-Hua Pan; Ru-Hong Cheng; Hong Yu; Wan-Qing Liao; Zhi-Rong Yao
Journal:  CNS Neurosci Ther       Date:  2014-01       Impact factor: 5.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.